GeneDx Holdings (NASDAQ: WGS) reported Q4 Revenue for the quarter at $95.3 million versus the consensus estimate of $61.7 million.

GUIDANCE:

GeneDx Holdings sees FY2025 revenue of $350-360 million, versus the consensus of $338.8 million.

For earnings history and earnings-related data on GeneDx Holdings (WGS) click here.